Sign up to save your podcasts
Or
Share Nephron Research Industry Expert Series: COVID-19 Testing Investment Implications with Dr. Robert Boorstein
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Nephron Research Industry Expert Series: COVID-19 Testing Investment Implications with Dr. Robert Boorstein
On July 9th, Dr. Robert Boorstein joined us for for a discussion focused on the investment implications from COVID-19 testing for the national labs and diagnostics manufacturers. Topics of discussion included detection and serology testing, as well as the laboratory operating environment. Companies in focus from our coverage included Bio-Rad (BIO), Danaher (DHR), Hologic (HOLX), LabCorp (LH), PerkinElmer (PKI), Quest Diagnostics (DGX), Quidel (QDEL), Thermo Fisher (TMO).
View all episodes
By Nephron Research LLCOn July 9th, Dr. Robert Boorstein joined us for for a discussion focused on the investment implications from COVID-19 testing for the national labs and diagnostics manufacturers. Topics of discussion included detection and serology testing, as well as the laboratory operating environment. Companies in focus from our coverage included Bio-Rad (BIO), Danaher (DHR), Hologic (HOLX), LabCorp (LH), PerkinElmer (PKI), Quest Diagnostics (DGX), Quidel (QDEL), Thermo Fisher (TMO).